Patents Assigned to THE GEORGE WASHINGTON UNIVERISTY
  • Patent number: 9988687
    Abstract: A method of classifying a patient for eligibility for cancer therapy based on the presence or absence of splicing variants in a sample of the patient's cancer tissue. Also, a method of screening cancer therapies for efficacy against splicing variants. More specifically, the methods relate to novel splicing variants of genes associated with cancer risk and survival, particularly splicing variants of PIK3CD, FGFR3, TSC2, RASGRP2, ITGA4, MET, NF1 and BAK1. Also more specifically, the methods relate to classifying a patient for eligibility for cancer therapy involving the use of GS-1101.
    Type: Grant
    Filed: March 5, 2015
    Date of Patent: June 5, 2018
    Assignee: THE GEORGE WASHINGTON UNIVERISTY
    Inventors: Norman Lee, Bi-Dar Wang